Over 150 Total Lots Up For Auction at One Location - CA 05/31

Cardiac arrhythmia monitoring devices market to reach $8,517.1 million by 2025

by John R. Fischer, Senior Reporter | December 12, 2017
Cardiology

Request Sample Report @ https://www.persistencemarketresearch.com/samples/12325

However, adverse events associated with the use of cardiac arrhythmia monitoring devices and product recall due to safety concerns, may hamper the demand for devices and restrain the growth of the market over forecast period. The dearth of trained and skilled specialists and professionals to operate, monitor and interpret the activities and signals generated by the advanced cardiac arrhythmia monitoring devices, may also hinder the growth of the global cardiac arrhythmia monitoring devices market. Unintended negative consequences of advanced ECG monitors in general care setting such as nuisance alarms, may create the alarm fatigue which is a widely recognized risk to patient health safety, are the few factors which may hinder the growth of the global cardiac arrhythmia monitoring devices market.

This report assesses trends are driving each market segment and offers analysis and insights into the cardiac arrhythmia monitoring devices market in specific regions. North America is estimated to dominate the cardiac arrhythmia monitoring devices market with a maximum value share of the overall market by the end of 2017. By 2025, North America and Europe markets are expected to account for over 58.0% share of the global cardiac arrhythmia monitoring devices market revenue. In terms of value, North America is estimated to be the dominant market, registering a CAGR of 6.6% over the forecast period.

Some key companies covered in this report include NUUBO Smart Solutions Technologies, SL, Koninklijke Philips N.V., GE Healthcare (General Electric Company), Welch Allyn - A Hill-Rom Inc. Company, Spacelabs Healthcare, Inc. (OSI Systems, Inc.), Nihon Kohden Corporation, Fukuda Denshi Co., Ltd., Biotelemetry, Inc., AliveCor, Inc., Biotronik, Inc., Medtronic Plc. and St. Jude Medical, LLC. (Abbott Laboratories).

These companies in the global cardiac arrhythmia monitoring devices market are striving to consolidate their position by means of acquiring small and large firms in the market. Companies are focusing towards increasing product development and up-gradation capacities to achieve economies of scale and to serve different markets to improve geographic footholds in the market.

Persistence Market Research Overview

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

SOURCE Persistence Market Research Pvt. Ltd.

Back to HCB News

You Must Be Logged In To Post A Comment